Skip to main content

Chronic Idiopathic Constipation News

Related terms: Constipation, Chronic Idiopathic, CIC

Could Constipation Be a Risk to the Heart?

WEDNESDAY, Oct. 30, 2024 – Constipation might increase a person’s risk of having a heart attack or stroke, particularly if they also have high blood pressure, a new study warns. People who are c...

Recommendations Issued for Managing Chronic Constipation

FRIDAY, Sept. 13, 2024 – Recommendations have been developed to address evaluation and management of chronic constipation, according to updated American Society of Colon and Rectal Surgeons...

FDA Approves Pizensy (lactitol) for the Treatment of Chronic Idiopathic Constipation in Adults

Braintree, Mass. March 02, 2020 -- Sebela Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Pizensy (lactitol) for oral solution for the once-daily ...

FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)

Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral trea...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Constipation

Related drug support groups

Linzess, Amitiza, Trulance